{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:52:47Z","timestamp":1794693167540,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11B4621N"],"award-info":[{"award-number":["11B4621N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1192221N"],"award-info":[{"award-number":["1192221N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"KU Leuven C1 funding grant","award":["C16\/17\/010"],"award-info":[{"award-number":["C16\/17\/010"]}]},{"name":"COST action","award":["BM1407"],"award-info":[{"award-number":["BM1407"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by recurrent airway infection and inflammation. There is no cure for PCD and to date there are no specific treatments available. Neutrophils are a crucial part of the immune system and are known to be dysfunctional in many inflammatory diseases. So far, the role of the neutrophils in PCD airways is largely unknown. The purpose of this study was to investigate the phenotype and function of airway neutrophils in PCD, and compare them to blood neutrophils.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Paired peripheral blood and spontaneously expectorated sputum samples from patients with PCD (n\u2009=\u200932) and a control group of patients with non-PCD, non-cystic fibrosis bronchiectasis (n\u2009=\u20095) were collected. The expression of neutrophil-specific surface receptors was determined by flow cytometry. Neutrophil function was assessed by measuring the extent of actin polymerization, production of reactive oxygen species (ROS) and release of neutrophil extracellular traps (NETs) in response to activating stimuli.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sputum neutrophils displayed a highly activated phenotype and were unresponsive to stimuli that would normally induce ROS production, actin polymerization and the expulsion of NETs. In addition, PCD sputum displayed high activity of neutrophil elastase, and impaired the efferocytosis by healthy donor macrophages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Sputum neutrophils in PCD are dysfunctional and likely contribute to ongoing inflammation in PCD airways. Further research should focus on anti-inflammatory therapies and stimulation of efferocytosis as a strategy to treat PCD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02280-7","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:02:43Z","timestamp":1671264163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sputum from patients with primary ciliary dyskinesia contains high numbers of dysfunctional neutrophils and inhibits efferocytosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Marfa","family":"Blanter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Cockx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesel","family":"Wittebols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abouelasrar Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirre","family":"De Bondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebmie","family":"P\u00f6rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Vanbrabant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Lorent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Gouwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"2280_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fped.2017.00135","volume":"5","author":"V Mirra","year":"2017","unstructured":"Mirra V, Werner C, Santamaria F. Primary ciliary dyskinesia: an update on clinical aspects, genetics, diagnosis, and future treatment strategies. Front Pediatr. 2017;5:135.","journal-title":"Front Pediatr"},{"key":"2280_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcdb.2020.11.007","volume":"110","author":"M Legendre","year":"2021","unstructured":"Legendre M, Zaragosi LE, Mitchison HM. Motile cilia and airway disease. Semin Cell Dev Biol. 2021;110:19\u201333.","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"2280_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00431-012-1785-6","volume":"172","author":"M Boon","year":"2013","unstructured":"Boon M, Jorissen M, Proesmans M, De Boeck K. Primary ciliary dyskinesia, an orphan disease. Eur J Pediatr. 2013;172(2):151\u201362.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2280_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MCP.0000000000000562","volume":"25","author":"EG Kocurek","year":"2019","unstructured":"Kocurek EG, Jagana R. Noncystic fibrosis bronchiectasis management: opportunities and challenges. Curr Opin Pulm Med. 2019;25(2):192\u2013200.","journal-title":"Curr Opin Pulm Med"},{"issue":"18","key":"2280_CR5","doi-asserted-by":"publisher","first-page":"9834","DOI":"10.3390\/ijms22189834","volume":"22","author":"T Paff","year":"2021","unstructured":"Paff T, Omran H, Nielsen KG, Haarman EG. Current and future treatments in primary ciliary dyskinesia. Int J Mol Sci. 2021;22(18):9834.","journal-title":"Int J Mol Sci"},{"issue":"10150","key":"2280_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392(10150):880\u201390.","journal-title":"Lancet"},{"issue":"2","key":"2280_CR7","doi-asserted-by":"publisher","first-page":"2003157","DOI":"10.1183\/13993003.03157-2020","volume":"58","author":"YH Giam","year":"2021","unstructured":"Giam YH, Shoemark A, Chalmers JD. Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism. Eur Respir J. 2021;58(2):2003157.","journal-title":"Eur Respir J"},{"issue":"22","key":"2280_CR8","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","volume":"383","author":"JD Chalmers","year":"2020","unstructured":"Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, Blasi F, Sibila O, et al. Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2020;383(22):2127\u201337.","journal-title":"N Engl J Med"},{"issue":"2","key":"2280_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1183\/09031936.99.14233999","volume":"14","author":"E Osika","year":"1999","unstructured":"Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, Tournier G, et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J. 1999;14(2):339\u201346.","journal-title":"Eur Respir J"},{"issue":"1","key":"2280_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1378\/chest.129.1.118","volume":"129","author":"A Bush","year":"2006","unstructured":"Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest. 2006;129(1):118\u201323.","journal-title":"Chest"},{"issue":"9","key":"2280_CR11","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/eji.200940294","volume":"40","author":"F Bazzoni","year":"2010","unstructured":"Bazzoni F, Tamassia N, Rossato M, Cassatella MA. Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur J Immunol. 2010;40(9):2360\u20138.","journal-title":"Eur J Immunol"},{"issue":"7","key":"2280_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1084\/jem.20122220","volume":"210","author":"A M\u00f3csai","year":"2013","unstructured":"M\u00f3csai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med. 2013;210(7):1283\u201399.","journal-title":"J Exp Med"},{"issue":"4","key":"2280_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4):248\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2280_CR14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1515\/hsz-2015-0271","volume":"397","author":"J Laval","year":"2016","unstructured":"Laval J, Ralhan A, Hartl D. Neutrophils in cystic fibrosis. Biol Chem. 2016;397(6):485\u201396.","journal-title":"Biol Chem"},{"issue":"5","key":"2280_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1165\/rcmb.2012-0492TR","volume":"48","author":"K Hoenderdos","year":"2013","unstructured":"Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;48(5):531\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2280_CR16","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3389\/fimmu.2020.01438","volume":"11","author":"G Cabrini","year":"2020","unstructured":"Cabrini G, Rimessi A, Borgatti M, Lampronti I, Finotti A, Pinton P, et al. Role of cystic fibrosis bronchial epithelium in neutrophil chemotaxis. Front Immunol. 2020;11:1438.","journal-title":"Front Immunol"},{"issue":"8","key":"2280_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","volume":"9","author":"HR Keir","year":"2021","unstructured":"Keir HR, Shoemark A, Dicker AJ, Perea L, Pollock J, Giam YH, et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021;9(8):873\u201384.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"2280_CR18","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.rmed.2015.08.008","volume":"109","author":"F Pedersen","year":"2015","unstructured":"Pedersen F, Marwitz S, Holz O, Kirsten A, Bahmer T, Waschki B, et al. Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients. Respir Med. 2015;109(10):1360\u20132.","journal-title":"Respir Med"},{"key":"2280_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3389\/fphar.2020.01096","volume":"11","author":"C Mitri","year":"2020","unstructured":"Mitri C, Xu Z, Bardin P, Corvol H, Touqui L, Tabary O. Novel anti-inflammatory approaches for cystic fibrosis lung disease: identification of molecular targets and design of innovative therapies. Front Pharmacol. 2020;11:1096.","journal-title":"Front Pharmacol"},{"key":"2280_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fimmu.2017.01126","volume":"8","author":"M Cockx","year":"2017","unstructured":"Cockx M, Gouwy M, Godding V, De Boeck K, Van Damme J, Boon M, et al. Neutrophils from patients with primary ciliary dyskinesia display reduced chemotaxis to CXCR2 ligands. Front Immunol. 2017;8:1126.","journal-title":"Front Immunol"},{"issue":"12","key":"2280_CR21","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.3390\/ijms22126172","volume":"22","author":"M Cockx","year":"2021","unstructured":"Cockx M, Blanter M, Gouwy M, Ruytinx P, Abouelasrar Salama S, Knoops S, et al. The antimicrobial activity of peripheral blood neutrophils is altered in patients with primary ciliary dyskinesia. Int J Mol Sci. 2021;22(12):6172.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2280_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2249.2008.03791.x","volume":"155","author":"E Fortunati","year":"2009","unstructured":"Fortunati E, Kazemier KM, Grutters JC, Koenderman L, Van den Bosch V. Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol. 2009;155(3):559\u201366.","journal-title":"Clin Exp Immunol."},{"key":"2280_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.820058","volume":"13","author":"M Blanter","year":"2022","unstructured":"Blanter M, Cambier S, De Bondt M, Vanbrabant L, P\u00f6rtner N, Abouelasrar Salama S, et al. Method matters: effect of purification technology on neutrophil phenotype and function. Front Immunol. 2022;13: 820058.","journal-title":"Front Immunol"},{"issue":"2","key":"2280_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10875-012-9807-8","volume":"33","author":"Z Weiszh\u00e1r","year":"2013","unstructured":"Weiszh\u00e1r Z, Bikov A, G\u00e1lffy G, Tam\u00e1si L, Ungv\u00e1ri I, Szalai C, et al. Elevated complement factor H levels in asthmatic sputa. J Clin Immunol. 2013;33(2):496\u2013505.","journal-title":"J Clin Immunol"},{"issue":"8","key":"2280_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","volume":"31","author":"C Summers","year":"2010","unstructured":"Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31(8):318\u201324.","journal-title":"Trends Immunol"},{"issue":"1","key":"2280_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155055","volume":"7","author":"S Cambier","year":"2022","unstructured":"Cambier S, Metzemaekers M, de Carvalho AC, Nooyens A, Jacobs C, Vanderbeke L, et al. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight. 2022;7(1): e155055.","journal-title":"JCI Insight"},{"issue":"3","key":"2280_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1710-1492-2-3-98","volume":"2","author":"P Lacy","year":"2006","unstructured":"Lacy P. Mechanisms of degranulation in neutrophils. Allergy Asthma Clin Immunol. 2006;2(3):98\u2013108.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"11","key":"2280_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1182\/bloodadvances.2017015578","volume":"2","author":"PHC Leliefeld","year":"2018","unstructured":"Leliefeld PHC, Pillay J, Vrisekoop N, Heeres M, Tak T, Kox M, et al. Differential antibacterial control by neutrophil subsets. Blood Adv. 2018;2(11):1344\u201355.","journal-title":"Blood Adv"},{"issue":"11","key":"2280_CR29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.humimm.2012.07.327","volume":"73","author":"BK Pliyev","year":"2012","unstructured":"Pliyev BK, Shmidt EI, Ivanova AV, Menshikov M. Circulating CD35(-)\/CD49d(+) neutrophils in influenza virus infection patients. Hum Immunol. 2012;73(11):1087\u201390.","journal-title":"Hum Immunol"},{"issue":"3","key":"2280_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jaci.2013.09.035","volume":"133","author":"JA Sigua","year":"2014","unstructured":"Sigua JA, Buelow B, Cheung DS, Buell E, Hunter D, Klancnik M, et al. CD49d-expressing neutrophils differentiate atopic from nonatopic individuals. J Allergy Clin Immunol. 2014;133(3):901-4.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2280_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.41605","volume":"73","author":"M Metzemaekers","year":"2021","unstructured":"Metzemaekers M, Malengier-Devlies B, Yu K, Vandendriessche S, Yserbyt J, Matthys P, et al. Synovial fluid neutrophils from patients with juvenile idiopathic arthritis display a hyperactivated phenotype. Arthritis Rheumatol. 2021;73(5):875\u201384.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"2280_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1023\/A:1010293809553","volume":"66","author":"VL Katanaev","year":"2001","unstructured":"Katanaev VL. Signal transduction in neutrophil chemotaxis. Biochemistry (Mosc). 2001;66(4):351\u201368.","journal-title":"Biochemistry (Mosc)"},{"issue":"1","key":"2280_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.13423","volume":"165","author":"A Singhal","year":"2022","unstructured":"Singhal A, Kumar S. Neutrophil and remnant clearance in immunity and inflammation. Immunology. 2022;165(1):22\u201343.","journal-title":"Immunology"},{"issue":"8","key":"2280_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/biom11081065","volume":"11","author":"JA Voynow","year":"2021","unstructured":"Voynow JA, Shinbashi M. Neutrophil elastase and chronic lung disease. Biomolecules. 2021;11(8):1065.","journal-title":"Biomolecules"},{"issue":"3","key":"2280_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1378\/chest.07-0569","volume":"132","author":"T Yamagata","year":"2007","unstructured":"Yamagata T, Sugiura H, Yokoyama T, Yanagisawa S, Ichikawa T, Ueshima K, et al. Overexpression of CD-11b and CXCR1 on circulating neutrophils: its possible role in COPD. Chest. 2007;132(3):890\u20139.","journal-title":"Chest"},{"issue":"1","key":"2280_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","volume":"4","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nat Rev Dis Primers. 2018;4(1):45.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2280_CR37","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1378\/chest.129.6.1673","volume":"129","author":"RW Vandivier","year":"2006","unstructured":"Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129(6):1673\u201382.","journal-title":"Chest"},{"issue":"5","key":"2280_CR38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1172\/JCI0213572","volume":"109","author":"RW Vandivier","year":"2002","unstructured":"Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, et al. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest. 2002;109(5):661\u201370.","journal-title":"J Clin Invest"},{"key":"2280_CR39","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2119\/molmed.2012.00005","volume":"18","author":"A Friggeri","year":"2012","unstructured":"Friggeri A, Banerjee S, Xie N, Cui H, De Freitas A, Zerfaoui M, et al. Extracellular histones inhibit efferocytosis. Mol Med. 2012;18:825\u201333.","journal-title":"Mol Med"},{"issue":"4","key":"2280_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/JLB.3A0620-342R","volume":"109","author":"IN Hsieh","year":"2021","unstructured":"Hsieh IN, Deluna X, White MR, Hartshorn KL. Histone H4 directly stimulates neutrophil activation through membrane permeabilization. J Leukoc Biol. 2021;109(4):763\u201375.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"2280_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1183\/13993003.01390-2015","volume":"47","author":"F Ratjen","year":"2016","unstructured":"Ratjen F, Waters V, Klingel M, McDonald N, Dell S, Leahy TR, et al. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J. 2016;47(3):829\u201336.","journal-title":"Eur Respir J"},{"issue":"11","key":"2280_CR42","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.3390\/ijms22115996","volume":"22","author":"M Oriano","year":"2021","unstructured":"Oriano M, Amati F, Gramegna A, De Soyza A, Mantero M, Sibila O, et al. Protease-antiprotease imbalance in bronchiectasis. Int J Mol Sci. 2021;22(11):5996.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2280_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1096\/fj.08-121228","volume":"23","author":"S Michlewska","year":"2009","unstructured":"Michlewska S, Dransfield I, Megson IL, Rossi AG. Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for TNF-alpha. FASEB J. 2009;23(3):844\u201354.","journal-title":"FASEB J"},{"issue":"4","key":"2280_CR44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/mi.2015.120","volume":"9","author":"R Subramaniam","year":"2016","unstructured":"Subramaniam R, Mukherjee S, Chen H, Keshava S, Neuenschwander P, Shams H. Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages. Mucosal Immunol. 2016;9(4):873\u201383.","journal-title":"Mucosal Immunol"},{"issue":"17","key":"2280_CR45","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1056\/NEJMoa1913590","volume":"383","author":"BC Trapnell","year":"2020","unstructured":"Trapnell BC, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, et al. Inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosis. N Engl J Med. 2020;383(17):1635\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"2280_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1128\/AAC.47.1.48-53.2003","volume":"47","author":"T Yamaryo","year":"2003","unstructured":"Yamaryo T, Oishi K, Yoshimine H, Tsuchihashi Y, Matsushima K, Nagatake T. Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother. 2003;47(1):48\u201353.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2280_CR47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","volume":"8","author":"HE Kobbernagel","year":"2020","unstructured":"Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C, et al. Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. Lancet Respir Med. 2020;8(5):493\u2013505.","journal-title":"Lancet Respir Med"},{"key":"2280_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12703\/r\/10-33","volume":"10","author":"PM Noone","year":"2021","unstructured":"Noone PM, Reddy SP. Recent advances in dead cell clearance during acute lung injury and repair. Fac Rev. 2021;10:33.","journal-title":"Fac Rev"},{"issue":"5","key":"2280_CR49","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41423-020-0412-0","volume":"17","author":"M Metzemaekers","year":"2020","unstructured":"Metzemaekers M, Gouwy M, Proost P. Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cell Mol Immunol. 2020;17(5):433\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2280_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11030-008-9076-x","volume":"12","author":"JF Cheng","year":"2008","unstructured":"Cheng JF, Jack R. CCR1 antagonists. Mol Divers. 2008;12(1):17\u201323.","journal-title":"Mol Divers"},{"issue":"13","key":"2280_CR51","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2174\/156802610791561255","volume":"10","author":"M Struthers","year":"2010","unstructured":"Struthers M, Pasternak A. CCR2 antagonists. Curr Top Med Chem. 2010;10(13):1278\u201398.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"2280_CR52","doi-asserted-by":"publisher","first-page":"R1707","DOI":"10.1152\/ajpregu.00627.2006","volume":"292","author":"Y Orr","year":"2007","unstructured":"Orr Y, Wilson DP, Taylor JM, Bannon PG, Geczy C, Davenport MP, et al. A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation. Am J Physiol Regul Integr Comp Physiol. 2007;292(4):R1707\u201316.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2280_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660760","volume":"12","author":"M Sekheri","year":"2021","unstructured":"Sekheri M, Othman A, Filep JG. \u03b22 integrin regulation of neutrophil functional plasticity and fate in the resolution of inflammation. Front Immunol. 2021;12: 660760.","journal-title":"Front Immunol"},{"issue":"2","key":"2280_CR54","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cei.12679","volume":"182","author":"SM Lewis","year":"2015","unstructured":"Lewis SM, Treacher DF, Edgeworth J, Mahalingam G, Brown CS, Mare TA, et al. Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation. Clin Exp Immunol. 2015;182(2):184\u201394.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2280_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10719-020-09912-4","volume":"37","author":"F Jin","year":"2020","unstructured":"Jin F, Wang F. The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins. Glycoconj J. 2020;37(2):277\u201391.","journal-title":"Glycoconj J"},{"issue":"5","key":"2280_CR56","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/art.10230","volume":"46","author":"G Fossati","year":"2002","unstructured":"Fossati G, Moots RJ, Bucknall RC, Edwards SW. Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum. 2002;46(5):1351\u201361.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2280_CR57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00441-017-2774-x","volume":"371","author":"A Ivetic","year":"2018","unstructured":"Ivetic A. A head-to-tail view of L-selectin and its impact on neutrophil behaviour. Cell Tissue Res. 2018;371(3):437\u201353.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2280_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","volume":"26","author":"K Van Raemdonck","year":"2015","unstructured":"Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S. CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev. 2015;26(3):311\u201327.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 2","key":"2280_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12949","volume":"48","author":"K De Filippo","year":"2018","unstructured":"De Filippo K, Rankin SM. CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease. Eur J Clin Invest. 2018;48(Suppl 2): e12949.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2280_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.2741\/e778","volume":"8","author":"SC Yang","year":"2016","unstructured":"Yang SC, Hwang TL. The potential impacts of formyl peptide receptor 1 in inflammatory diseases. Front Biosci (Elite Ed). 2016;8(3):436\u201349.","journal-title":"Front Biosci (Elite Ed)"},{"issue":"3","key":"2280_CR61","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1365-2249.2003.02245.x","volume":"133","author":"W Reinisch","year":"2003","unstructured":"Reinisch W, Lichtenberger C, Steger G, Tillinger W, Scheiner O, Gangl A, et al. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo. Clin Exp Immunol. 2003;133(3):476\u201384.","journal-title":"Clin Exp Immunol"},{"issue":"18","key":"2280_CR62","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2016-01-688887","volume":"127","author":"C Silvestre-Roig","year":"2016","unstructured":"Silvestre-Roig C, Hidalgo A, Soehnlein O. Neutrophil heterogeneity: implications for homeostasis and pathogenesis. Blood. 2016;127(18):2173\u201381.","journal-title":"Blood"},{"issue":"2\u20133","key":"2280_CR63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0952-3278(03)00073-5","volume":"69","author":"AM Tager","year":"2003","unstructured":"Tager AM, Luster AD. BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot Essent Fatty Acids. 2003;69(2\u20133):123\u201334.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"2280_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijms.5.1","volume":"5","author":"DS O'Mahony","year":"2008","unstructured":"O\u2019Mahony DS, Pham U, Iyer R, Hawn TR, Liles WC. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. Int J Med Sci. 2008;5(1):1\u20138.","journal-title":"Int J Med Sci"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02280-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02280-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02280-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:09:53Z","timestamp":1671534593000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02280-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02280-7","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants (or their parents) signed an informed consent. The study protocol (S57236[ML11095]) was approved by the ethical committee of KU Leuven\/UZ Leuven.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"359"}}